Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.00 (+1.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Invested Capital (2020 - 2021)

Updated

Context Therapeutics' Invested Capital came in at $48.27 million for Q4 2021, compared with -$10.97 million a year earlier.

Analysis

Context Therapeutics (CNTX) Invested Capital (2020 - 2021) Analysis & Trends

  • Going back by year, Invested Capital was -$10.97 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 126.18 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 64.89 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 82.72 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 38.08 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 148.69 Bn
10 Context Therapeutics 21.97 Mn -218.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 48.27 Mn
Sep 30, 2021 -23.21 Mn
Dec 31, 2020 -10.97 Mn
API Access

Context Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=CNTX&period=max&api_key=YOUR_API_KEY